Skip to main content
UK clinical trials - updated daily from ClinicalTrials.gov
TrialConnect
← Back to Search
Looking for participantsNA

Study on Optimal Temperature During Cardiopulmonary Bypass (THERMIC-4)

Sponsor: University of Leicester

NCT ID: NCT05996120

View on ClinicalTrials.gov ↗

At a glance

What the study gets you
Access to the study treatment being tested
Type of study
Interventional (receives a drug or procedure)
Time in hospital
In-person visits at study sites — visit count not specified by the sponsor
Drug or intervention
Hypothermic Cardiopulmonary Bypass (procedure), Normothermic Cardiopulmonary Bypass (procedure)
How long the study runs
Study runs about 21 months (dates as stated)
About the drug or intervention
Hypothermic Cardiopulmonary Bypass — procedure: Mild hypothermia (between 32 - 35 °C) during cardiopulmonary bypass · Normothermic Cardiopulmonary Bypass — procedure: Normothermia (active maintenance of temperature between 36.5 °C to 37.5°C; no active cooling below 36.5 °C) during cardiopulmonary bypass
Patient visit burden
Not specified by the sponsor
Type of study
Testing a treatment
Ages
18 Years and over
Who
All
Number of participants
100
Started
2024-05-20
Last checked
2025-03

Plain English Summary

What is this study?

  • • Testing a new treatment for ischemic heart disease
  • • NA - 100 participants
  • • In order to perform heart surgery, a machine called cardiopulmonary bypass (CPB), or more commonly known as a heart-lung machine, is used to maintain the circulation of oxygenated blood needed by the rest of the body and its organs

Who can take part?

  • • Ages 18 Years and over
  • • Diagnosed with ischemic heart disease

Where?

  • • Leicester - Glenfield Hospital, University Hospitals of Leicester NHS Trust
  • • Blackpool - Blackpool Victoria Hospital, Blackpool Teaching Hospitals NHS Foundation Trust
  • • Bristol - University Hospitals Bristol and Weston NHS Foundation Trust
  • • Cottingham - Castle Hill Hospital, Hull University Teaching Hospitals NHS Trust
  • • +7 more UK sites

This is a simplified summary. Always discuss with your doctor before making any decisions.

About This Trial

In order to perform heart surgery, a machine called cardiopulmonary bypass (CPB), or more commonly known as a heart-lung machine, is used to maintain the circulation of oxygenated blood needed by the rest of the body and its organs. Historically, when a patient is connected to CPB, their body is cooled below the normal body temperature. This is known as hypothermia. This is because scientific studies have previously shown that reduced body temperature lowers metabolism and therefore offers more protection to the brain and other organs due to the reduced oxygen requirement. The evidence supporting this practice, however, has been challenged throughout the history of cardiac surgery, with studies supporting that normothermia, or normal body temperature, is a safe alternative. Despite this, the practice of hypothermia has persisted. Published data from a survey of 139 cardiac surgeons in the United Kingdom showed that 84% still routinely employ hypothermic CPB during surgery. To assess whether normothermic or hypothermic CPB is safer, a clinical trial requiring a large sample size and high recruitment rates will be required. Therefore, the investigators aim to assess firstly the feasibility of trial recruitment and allocation adherence in this study. 100 adults across 10 different cardiac surgery centres in the United Kingdom will be recruited to a multicentre feasibility randomised controlled trial comparing normothermia (active comparator) against hypothermia (control comparator) during cardiopulmonary bypass in cardiac surgery. This study will also test the ability of the Cardiothoracic Interdisciplinary Research Network (CIRN), a trainee-led research collaborative, to collect pilot data on Major Adverse Cardiac and Cerebrovascular Events (MACCE) using a regulation-approved electronic application HealthBitⓇ. Participants will also be asked to complete quality of life surveys. The results of this study will subsequently inform a large, adequately powered randomised controlled trial for optimal temperature management during CPB.

More detail

Primary Objective To assess the feasibility of trial recruitment and delivery to target in the United Kingdom of a multicentre randomised controlled trial on normothermia versus hypothermia during cardiopulmonary bypass in adult cardiac surgery. Secondary Objective To assess the feasibility of conducting a multicentre randomized controlled trial (RCT) using a novel Good Clinical Practice (GCP) approved remote data capture as the primary trial database alongside analysis of routinely collected healthcare data. To obtain pilot data, undertaken by the Cardiothoracic Interdisciplinary Research Network (CIRN), to inform a subsequent large, adequately powered RCT for optimal temperature management during CPB.

Ischemic Heart DiseaseValvular Heart DiseaseCardiovascular DiseasesSurgery-Complications

How this trial compares with your answers

Answer 2 more questions to improve match

What we know so far

Condition· Matched your search
Age· Tell us your age for better matching
Gender· Tell us your sex for better matching

Still need:

  • • Tell us your age for better matching
  • • Tell us your sex for better matching

Preliminary match based on your answers. Full eligibility requires on-site assessment including medical history, physical exam, and lab tests. This does not guarantee enrolment.

Eligibility at a Glance

Key info

  • Age: 18 Years and over
  • Who can join: All genders

Treatment history

Treatments you must have had:

  • ✓ deep hypothermic arrest

What the study is looking for

  • ✓INCLUSION CRITERIA
  • ✓Participants may enter the trial if all of the following apply
  • ✓Adult patients (≥ 18 years) scheduled for coronary artery bypass surgery and/or valve replacement/ repair, either in...
  • ✓European System for heart Operative Risk Evaluation (EuroSCORE) II of 2 or higher.
  • ✓Able to understand and communicate to provide agreement to take part.
See the full criteria
INCLUSION CRITERIA Participants may enter the trial if all of the following apply 1. Adult patients (≥ 18 years) scheduled for coronary artery bypass surgery and/or valve replacement/ repair, either in the elective or urgent setting. 2. European System for Cardiac Operative Risk Evaluation (EuroSCORE) II of 2 or higher. 3. Able to understand and communicate to provide informed consent. 4. Able to read and understand the English language. EXCLUSION CRITERIA Participants may not enter the trial if any of the following apply: 1. Patients undergoing coronary artery bypass surgery in combination with other procedures including cardiac or vascular procedures that require deep hypothermic arrest. 2. Patients undergoing emergency or salvage surgery. 3. Patients undergoing off-pump cardiac surgery. 4. Patients who are participating in another interventional trial. 5. Unable to provide informed consent.

Where Is This Study? (11 UK sites)

Glenfield Hospital, University Hospitals of Leicester NHS Trust

Leicester LE3 9QP, United Kingdom

Recruiting
Site contact (verified)

Blackpool Victoria Hospital, Blackpool Teaching Hospitals NHS Foundation Trust

Blackpool FY3 8NR, United Kingdom

NOT_YET_RECRUITING
Site contact (verified)

University Hospitals Bristol and Weston NHS Foundation Trust

Bristol BS1 3NU, United Kingdom

Recruiting
Site contact (verified)

Castle Hill Hospital, Hull University Teaching Hospitals NHS Trust

Cottingham HU16 5JQ, United Kingdom

Recruiting
Site contact (verified)

Golden Jubilee National Hospital, NHS Golden Jubilee

Glasgow G81 4DY, United Kingdom

Recruiting

King's College Hospital, King's College Hospital NHS Foundation Trust

London SE5 9RS, United Kingdom

Recruiting
Site contact (verified)

Royal Brompton Hospital, Guy's and St Thomas' NHS Foundation Trust

London SW3 6NP, United Kingdom

NOT_YET_RECRUITING
Site contact (verified)

Harefield Hospital, Guy's and St Thomas' NHS Foundation Trust

London UB9 6JH, United Kingdom

NOT_YET_RECRUITING
Hospital R&D contact (matched)

Main Email: gstt.research.rbhh@nhs.net

gstt.research.rbhh@nhs.netn/a

John Radcliffe Hospital, Oxford University Hospitals NHS Foundation Trust

Oxford OX3 9DU, United Kingdom

Recruiting
Site contact (verified)

Derriford Hospital, Plymouth University Hospitals NHS Trust

Plymouth PL6 8DH, United Kingdom

Recruiting
Site contact (verified)
Omar Zibdeho.zibdeh@nhs.net

Northern General Hospital, Sheffield Teaching Hospitals NHS Foundation Trust

Sheffield S5 7AU, United Kingdom

Recruiting
Site contact (verified)
Olaniran Omodaraolaniran.omodara@nhs.net

How to Get in Touch

Gavin J Murphy, FRCS, MD, MBChB, BSc

Sponsor contact

CONTACT

0116 258 3054 gjm19@le.ac.uk

Ann Cheng, MBChB, MSc

Sponsor contact

CONTACT

ann.cheng1@nhs.net
Data sourced from ClinicalTrials.gov · Last verified: 2025-03